|Articles|September 26, 2018
Catalent Selected to Provide Oral Delivery Systems
Advertisement
GB Sciences, Inc. and Catalent Pharma Solutions, a global provider of delivery technologies and development solutions, announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences’ proprietary active pharmaceutical ingredients for its Parkinson’s disease therapies.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5